COMMUNIQUÉS West-GlobeNewswire

NMDP℠ Raises $1.1 Million at Annual Gala Expanding Access to Life-Saving Cell Therapies

03/10/2024 - 15:00

MINNEAPOLIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- NMDP ℠ (formerly Be The Match), a global nonprofit leader in cell therapy, raised $1.1 million during its 17th annual fundraising gala last month at The Depot Minneapolis. [...]

Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics

03/10/2024 - 15:00

SALT LAKE CITY and FREMONT, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Ultima Genomics, Inc., a developer of a revolutionary [...]

Imprivata Joins FIDO Alliance to Help Advance Passwordless Authentication in Healthcare and other Mission-Critical Industries

03/10/2024 - 15:00

Imprivata will harness its extensive history of innovation in support of FIDO’s mission to eliminate passwords in favor of more modern, secure, and user-centric authentication methods WALTHAM, Mass., Oct. 03, 2024 ( [...]

AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis

03/10/2024 - 14:45

OCALA, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States Patent and Trademark Office (USPTO) has granted U.S. patent No. 12, [...]

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

03/10/2024 - 14:30

SCOTTSDALE, Ariz., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and [...]

Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases

03/10/2024 - 14:30

NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Annovis Bio Inc. (NYSE: ANVS) announces the availability of a broadcast titled, “Transforming Alzheimer’s Treatment: Innovative Combinations to Boost [...]

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

03/10/2024 - 14:30

WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and up to $75,000 in funding [...]

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

03/10/2024 - 14:30

Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness products via a secure [...]

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate

03/10/2024 - 14:30

The expansion of the strategic partnership reinforces the solid foundation of the collaborative efforts that commenced in April 2024 The collaboration supports Teva's Pivot to Growth strategy and adds to the company’s [...]

NMS Capital Portfolio Company Surplus Solutions Expands Internationally; Announces Partnership with FAMECO Group ApS

03/10/2024 - 14:01

NEW YORK and STRASBOURG, France, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today that it has expanded internationally via a [...]

Spectral AI Completes Proof of Concept for Wound Measurement Technology

03/10/2024 - 14:00

Provides Clinicians with Superior Wound Size Measurement Information that Improves Patient Treatment Decisions DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company [...]

Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025

03/10/2024 - 14:00

-- New J-code issued by the Centers for Medicare and Medicaid Services expected to standardize and streamline billing and reimbursement -- TAMPA, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ [...]

Monthly information on share capital and company voting rights

02/10/2024 - 22:30

(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

02/10/2024 - 22:30

(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 02 oct. 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

02/10/2024 - 22:30

Phase 1 study showed significant lung uptake and enhanced epithelial lining fluid (ELF) and alveolar macrophage (AM) concentrations of SPR719 (active moiety of SPR720) CAMBRIDGE, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE [...]

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/10/2024 - 22:30

SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]

Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference

02/10/2024 - 22:28

VANCOUVER, British Columbia and BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/10/2024 - 22:15

WALTHAM, Mass., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]

Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions

02/10/2024 - 22:15

AUDUBON, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announces the continued growth and expansion of its orthopedic trauma product portfolio. [...]